These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 9413099

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Immune response to measles, mumps & rubella vaccine at 9, 12 & 15 months of age.
    Singh R, John TJ, Cherian T, Raghupathy P.
    Indian J Med Res; 1994 Oct; 100():155-9. PubMed ID: 7851964
    [Abstract] [Full Text] [Related]

  • 25. Lidocaine-prilocaine patch decreases the pain associated with the subcutaneous administration of measles-mumps-rubella vaccine but does not adversely affect the antibody response.
    Halperin SA, McGrath P, Smith B, Houston T.
    J Pediatr; 2000 Jun; 136(6):789-94. PubMed ID: 10839878
    [Abstract] [Full Text] [Related]

  • 26. Rational use of measles, mumps and rubella (MMR) vaccine.
    Carter H, Campbell H.
    Drugs; 1993 May; 45(5):677-83. PubMed ID: 7686463
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of immunogenicity of simultaneous and nonsimultaneous vaccination with MMR and JE vaccine among 15-month-old children.
    Tseng CY, Hwang KP, Lin KH, Chen HY, Lu CC, Chiang CH.
    Acta Paediatr Taiwan; 1999 May; 40(3):161-5. PubMed ID: 10910607
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Serologic responses to measles, mumps, and rubella (MMR) vaccine in healthy infants: failure to respond to measles and mumps components may influence decisions on timing of the second dose of MMR.
    Mitchell LA, Tingle AJ, Décarie D, Lajeunesse C.
    Can J Public Health; 1998 May; 89(5):325-8. PubMed ID: 9813922
    [Abstract] [Full Text] [Related]

  • 31. A randomised single blind trial of a combined mumps measles rubella vaccine to evaluate serological response and reactions in the UK population.
    Edees S, Pullan CR, Hull D.
    Public Health; 1991 Mar; 105(2):91-7. PubMed ID: 2068243
    [Abstract] [Full Text] [Related]

  • 32. Duration of the immune response to MMR vaccine in children of two age-different groups.
    Li Volti S, Giammanco-Bilancia G, Grassi M, Garozzo R, Gluck R, Giammanco G.
    Eur J Epidemiol; 1993 May; 9(3):311-4. PubMed ID: 8405317
    [Abstract] [Full Text] [Related]

  • 33. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D.
    Schweiz Med Wochenschr; 1997 Jun 28; 127(26):1124-33. PubMed ID: 9312835
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Re: V. Usonis et al.: Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children (Infection 26 [1998] 222-226).
    Nalin D.
    Infection; 1999 Jun 28; 27(2):134-5. PubMed ID: 10219647
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children.
    Vesikari T, Ala-Laurila EL, Heikkinen A, Terho A, D'Hondt E, André FE.
    Am J Dis Child; 1984 Sep 28; 138(9):843-7. PubMed ID: 6383020
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells.
    Just M, Berger R, Glück R, Wegmann A.
    Dev Biol Stand; 1986 Sep 28; 65():25-7. PubMed ID: 3549399
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.